Abstract: An adjustable reflex sight comprising an elongated sight housing comprising an outer tube and an inner tube pivotably mounted within the outer tube and holding an optical element for pivoting movement therewith, a sight adjustment mechanism mounted to the housing having an adjustable member movably mounted within the adjustment mechanism for altering a tilt angle of the inner tube in relation to the outer tube thereby adjusting the sight, a first adjustment device interlinked with a second adjustment device, wherein the first adjustment device is adjustably positionable about an axis of rotation for actuating said adjustable member, thereby altering the tilt angle of the inner tube, and the second adjustment device is adjustably positionable about the axis of rotation, such that the interlinked first adjustment device and the adjustable member are moved along the axis of rotation in response to rotation of the second adjustment device.

Abstract: The present invention relates to microorganisms for use in the treatment and/or prevention of skin conditions by topical application. In particular, the microorganisms are for use in the treatment and/or prevention of loss of skin barrier function, inflammatory conditions and/or growth of pathogenic microorganism. The invention further relates to pharmaceutical or cosmetic compositions or products comprising the microorganisms Provided is also a cosmetic use of the microorganisms or compositions for application on the skin and a cosmetic method, in particular to improve the appearance of the skin.

Abstract: The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, preferably for the treatment and/or prevention of gingivitis and/or peridontitis. In particular, the present invention relates to microorganisms or mixtures thereof for use as probiotic agents for forming co-aggregates with microorganisms associated with gingivitis and/or peridontitis. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the probiotic microorganisms as active agents as well as a method of production thereof.

Abstract: An adjustable reflex sight comprising an elongated sight housing comprising an outer tube and an inner tube pivotably mounted within the outer tube and holding an optical element for pivoting movement therewith, a sight adjustment mechanism mounted to the housing having an adjustable member movably mounted within the adjustment mechanism for altering a tilt angle of the inner tube in relation to the outer tube thereby adjusting the sight, a first adjustment device interlinked with a second adjustment device, wherein the first adjustment device is adjustably positionable about an axis of rotation for actuating said adjustable member, thereby altering the tilt angle of the inner tubed, and the second adjustment device is adjustably positionable about the axis of rotation, such that the interlinked first adjustment device and the adjustable member are moved along the axis of rotation in response to rotation of the second adjustment device.

Abstract: A reflex sight includes an elongated sight housing having an outer tube and an inner tube defining a light channel with an optical axis, wherein the inner tube is pivotally secured within an end of the outer tube and has an end section forming an outer perimeter section, which is provided with separate convex sections. The separate convex sections of the inner tube are arranged to fit into the separate concave support sections in the outer tube, wherein the end section of the inner tube is pivotally received within the end section of the outer tube.

Abstract: The present invention relates to at least one probiotic strain of Lactobacillus for use in a subject for the prevention and/or treatment of celiac disease autoimmunity (CDA), or for use in the prevention and/or treatment of celiac disease (CD). A preferred composition for use according to the invention is a composition comprising a combination of Lactobacillus paracasei and Lactobacillus plantarum, especially L. paracasei 8700:2 (DSM 13434) in combination with L. plantarum HEAL 9 (DSM 15312).

Abstract: A scheduler and method for scheduling data transmission in a wireless communication system are disclosed. The scheduler buffers data packets in a buffer and monitors status of the buffer. The buffered data packets will remain in the buffer, until the buffer contains a data packet which is associated with a priority level higher than a priority level of a predefined priority threshold. Then, the scheduler selects a modulation and coding scheme for the buffered data packets and sends the buffered data packets to a radio unit for transmission.

Abstract: The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, in particular for use in the treatment and/or prevention of dental caries and/or periodontal disease. In particular, the present invention relates to microorganisms or mixtures thereof for use as an anti-inflammatory agent in the oral cavity for reducing or inhibiting the release of certain inflammatory factors. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the microorganisms as probiotic agents as well as a method of production thereof.

Abstract: The invention relates to at least one probiotic strain chosen from Lactobacillus paracasei 8700:2 (DSM 13434) and/or at least one probiotic strain of Lactobacillus piantarum, for use in the treatment and/or prevention of trabecular bone loss, in a mammal, preferably in anon-rodent mammal, more preferably in a human, most preferably in a peri-menopausal woman, post-menopausal woman or a woman six years or less after onset of menopause.

Abstract: The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, in particular for use in the treatment and/or prevention of dental caries and/or periodontal disease. In particular, the present invention relates to microorganisms or mixtures thereof for use as an anti-inflammatory agent in the oral cavity for reducing or inhibiting the release of certain inflammatory factors. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the microorganisms as probiotic agents as well as a method of production thereof.

Abstract: The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, preferably for the treatment and/or prevention of gingivitis and/or peridontitis. In particular, the present invention relates to microorganisms or mixtures thereof for use as probiotic agents for forming co-aggregates with microorganisms associated with gingivitis and/or peridontitis. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the probiotic microorganisms as active agents as well as a method of production thereof.

Abstract: The present invention relates to at least one probiotic strain of Lactobacillus for use in a subject for the prevention and/or treatment of celiac disease autoimmunity (CDA), or for use in the prevention and/or treatment of celiac disease (CD). A preferred composition for use according to the invention is a composition comprising a combination of Lactobacillus paracasei and Lactobacillus plantarum, especially L. paracasei 8700:2 (DSM 13434) in combination with L. plantarum HEAL 9 (DSM 15312).

Abstract: A scheduler (400) and method for scheduling data transmission in a wireless communication system (100) are disclosed. The scheduler (400) buffers data packets in a buffer and monitories status of the buffer. The buffered data packets will remain in the buffer, until the buffer contains a data packet which is associated with a priority level higher than a priority level of a predefined priority threshold or when the total amount of data packets in the buffer reaches a predefined Buffer Threshold Set Point. Then the scheduler (400) selects modulation and coding scheme for the buffered data packets and sends the buffered data packets to the radio unit for transmission.